Novel Candida albicans aspartyl protease inhibitor. II. A new pepstatin-ahpatinin group inhibitor, YF-044P-D.
Sato
T
T
Drug Serendipity Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd., Tokyo, Japan.
Shibazaki
M
M
Yamaguchi
H
H
Abe
K
K
Matsumoto
H
H
Shimizu
M
M
D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors*; D002176:Candida albicans / Q000201:enzymology*; D009682:Magnetic Resonance Spectroscopy; D009842:Oligopeptides / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology; D011480:Protease Inhibitors / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology; D013055:Spectrophotometry, Infrared; D013056:Spectrophotometry, Ultraviolet; D013302:Streptomyces / Q000737:chemistry
D009842:Oligopeptides; D011480:Protease Inhibitors; C088534:YF 044P-D; D016282:Aspartic Acid Endopeptidases